+Compare
BNTX
Stock ticker:
NASDAQ
AS OF
Aug 5 closing price
Price
$183.11
Change
+$2.67 (+1.48%)
Capitalization
44.5B

BNTX BioNTech SE American Depositary Share Forecast, Technical & Fundamental Analysis

a company, which focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches
Industry Biotechnology
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Aug 05, 2022

BNTX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for BNTX turned positive on August 03, 2022. Looking at past instances where BNTX's MACD turned positive, the stock continued to rise in 21 of 23 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on July 28, 2022. You may want to consider a long position or call options on BNTX as a result. In of 44 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

BNTX moved above its 50-day moving average on June 30, 2022 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for BNTX crossed bullishly above the 50-day moving average on July 07, 2022. This indicates that the trend has shifted higher and could be considered a buy signal. In of 8 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BNTX advanced for three days, in of 187 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 145 cases where BNTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BNTX broke above its upper Bollinger Band on August 03, 2022. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.753) is normal, around the industry mean (26.225). P/E Ratio (3.643) is within average values for comparable stocks, (100.314). Projected Growth (PEG Ratio) (0.046) is also within normal values, averaging (4.703). Dividend Yield (0.013) settles around the average of (0.024) among similar stocks. P/S Ratio (2.015) is also within normal values, averaging (317.105).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BNTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BNTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

AI

View a ticker or compare two or three

BNTX
Buy/Sell Ratings
 
 
Technical Analysis# Of IndicatorsAvg. Odds
   
   
 
AI
A.I. Advisor
published Earnings

BNTX is expected to report earnings to fall 49.37% to $7.21 per share on August 08

BioNTech SE American Depositary Share BNTX Stock Earnings Reports
Q2'22
Est.
$7.21
Q1'22
Beat
by $5.08
Q4'21
Beat
by $4.74
Q3'21
Beat
by $1.81
Q2'21
Beat
by $3.23
The last earnings report on May 09 showed earnings per share of $14.24, beating the estimate of $9.16. With 1.57M shares outstanding, the current market capitalization sits at 44.50B.
AI
A.I.Advisor
published Dividends

BNTX paid dividends on June 17, 2022

BioNTech SE American Depositary Share BNTX Stock Dividends
А dividend of $4.22 per share was paid with a record date of June 17, 2022, and an ex-dividend date of June 02, 2022. Read more...
AI
A.I. Advisor
published General Information

General Information

a company, which focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
An der Goldgrube 12
Phone
+49 613190840
Employees
3082
Web
https://www.biontech.de

Interesting Tickers

1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TWTR42.521.46
+3.56%
Twitter
EGAN9.560.19
+2.03%
eGain Corp
CNOB27.19-0.02
-0.07%
ConnectOne Bancorp
ACHV4.96-0.01
-0.20%
Achieve Life Sciences
CERT23.74-0.11
-0.46%
Certara

BNTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BNTX has been closely correlated with MRNA. These tickers have moved in lockstep 85% of the time. This A.I.-generated data suggests there is a high statistical probability that if BNTX jumps, then MRNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BNTX
1D Price
Change %
BNTX100%
+1.48%
MRNA - BNTX
85%
Closely correlated
-3.78%
CVAC - BNTX
54%
Loosely correlated
+0.44%
VIR - BNTX
51%
Loosely correlated
+3.15%
MRVI - BNTX
48%
Loosely correlated
+2.28%
VXRT - BNTX
47%
Loosely correlated
+5.12%
More